MORPHEUS RISK LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10Company Documents
Date | Description |
---|---|
24/03/2524 March 2025 | Total exemption full accounts made up to 2024-12-31 |
28/01/2528 January 2025 | Appointment of Mr Thomas Gwyn Davies as a director on 2025-01-22 |
31/12/2431 December 2024 | Annual accounts for year ending 31 Dec 2024 |
24/12/2424 December 2024 | Confirmation statement made on 2024-12-17 with updates |
22/05/2422 May 2024 | Total exemption full accounts made up to 2023-12-31 |
29/01/2429 January 2024 | Sub-division of shares on 2024-01-15 |
18/01/2418 January 2024 | Confirmation statement made on 2023-12-17 with no updates |
31/12/2331 December 2023 | Annual accounts for year ending 31 Dec 2023 |
14/02/2314 February 2023 | Total exemption full accounts made up to 2022-12-31 |
21/01/2321 January 2023 | Confirmation statement made on 2022-12-17 with no updates |
31/12/2231 December 2022 | Annual accounts for year ending 31 Dec 2022 |
10/10/2210 October 2022 | Total exemption full accounts made up to 2021-12-31 |
22/01/2222 January 2022 | Confirmation statement made on 2021-12-17 with no updates |
31/12/2131 December 2021 | Annual accounts for year ending 31 Dec 2021 |
12/01/2112 January 2021 | DIRECTOR APPOINTED MR SIMON JOHN DIXON |
12/01/2112 January 2021 | DIRECTOR APPOINTED LORD EVAN MERVYN DAVIES |
18/12/2018 December 2020 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company